Due to the lack of more efficient diagnostic tools for monkeypox, its spread
remains unchecked, presenting a formidable challenge to global health. While
the high efficacy of deep learning models for monkeypox diagnosis has been
demonstrated in related studies, the overlook of inference speed, the parameter
size and diagnosis performance for early-stage monkeypox renders the models
inapplicable in real-world settings. To address these challenges, we proposed
an ultrafast and ultralight network named Fast-MpoxNet. Fast-MpoxNet possesses
only 0.27M parameters and can process input images at 68 frames per second
(FPS) on the CPU. To counteract the diagnostic performance limitation brought
about by the small model capacity, it integrates the attention-based feature
fusion module and the multiple auxiliary losses enhancement strategy for better
detecting subtle image changes and optimizing weights. Using transfer learning
and five-fold cross-validation, Fast-MpoxNet achieves 94.26% Accuracy on the
Mpox dataset. Notably, its recall for early-stage monkeypox achieves 93.65%. By
adopting data augmentation, our model's Accuracy rises to 98.40% and attains a
Practicality Score (A new metric for measuring model practicality in real-time
diagnosis application) of 0.80. We also developed an application system named
Mpox-AISM V2 for both personal computers and mobile phones. Mpox-AISM V2
features ultrafast responses, offline functionality, and easy deployment,
enabling accurate and real-time diagnosis for both the public and individuals
in various real-world settings, especially in populous settings during the
outbreak. Our work could potentially mitigate future monkeypox outbreak and
illuminate a fresh paradigm for developing real-time diagnostic tools in the
healthcare field